This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Compared to Estimates, Envista (NVST) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Envista (NVST) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Envista (NVST) delivered earnings and revenue surprises of 20% and 1.49%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Envista (NVST) Q1 Earnings Expected to Decline
by Zacks Equity Research
Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Continue to Hold NVST Stock in Your Portfolio?
by Zacks Equity Research
Investors are optimistic about Envista, thanks to its strong momentum in the Specialty Products and Technologies segment.
Solventum Partners With SprintRay for Same-Day Dental Restorations
by Zacks Equity Research
SOLV partners with SprintRay to introduce an innovative solution for same-day dental restorations, enhancing efficiency, precision and patient care in digital dentistry.
Why Is Envista (NVST) Down 18.2% Since Last Earnings Report?
by Zacks Equity Research
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Reasons to Retain Envista Stock in Your Portfolio for Now
by Zacks Equity Research
NVST's impressive long-term growth initiatives appear promising. Yet, a leveraged balance sheet is worrisome.
NVST Stock Up on Q4 Earnings and Revenue Beat, Operating Margin Crashes
by Zacks Equity Research
Envista delivers better-than-expected top and bottom-line results for the fourth quarter of 2024.
Here's What Key Metrics Tell Us About Envista (NVST) Q4 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Envista (NVST) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Envista (NVST) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Envista (NVST) delivered earnings and revenue surprises of 4.35% and 1.09%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Retain Envista Stock in Your Portfolio for Now
by Zacks Equity Research
NVST's strong focus on international market expansion appears promising. Yet, a leveraged balance sheet is worrisome.
Is Envista (NVST) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NVST or LZAGY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NVST vs. LZAGY: Which Stock Is the Better Value Option?
Reasons to Retain Envista Stock in Your Portfolio for Now
by Zacks Equity Research
NVST's Specialty Products and Technologies business' strong performance appears promising. Yet, a leveraged balance sheet is worrisome.
Deciphering Envista (NVST) International Revenue Trends
by Zacks Equity Research
Evaluate Envista's (NVST) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Envista Stock Climbs on Q3 Earnings and Revenue Beat, Margins Crash
by Zacks Equity Research
NVST delivers better-than-expected top and bottom-line performance in the third quarter of 2024.
Compared to Estimates, Envista (NVST) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Envista (NVST) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Envista (NVST) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Envista (NVST) delivered earnings and revenue surprises of 33.33% and 1.47%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
ICU Medical (ICUI) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
ICU Medical (ICUI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Envista (NVST) Q3 Earnings Expected to Decline
by Zacks Equity Research
Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Envista (NVST) International Revenue Trends Deserve Your Attention
by Zacks Equity Research
Examine Envista's (NVST) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Envista (NVST) Q2 Earnings & Revenues Miss, Margins Fall
by Zacks Equity Research
Envista's (NVST) Spark division sales witness a slowdown in the second quarter due to the deferment of a larger portion of case revenues.
Here's What Key Metrics Tell Us About Envista (NVST) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Envista (NVST) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Envista (NVST) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Envista (NVST) delivered earnings and revenue surprises of -59.26% and 2.30%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?